228 results
8-K
EX-3.2
CELU
Celularity Inc - Ordinary Shares
22 Jul 21
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
4:13pm
of the State of Delaware (“DGCL”).
Section 5. Annual Meeting.
(a) The annual meeting of the stockholders of the corporation, for the purpose of election … .
(a) Special meetings of the stockholders of the corporation may be called, for any purpose as is a proper matter for stockholder action under Delaware law, only
S-1
EX-3.3
CELU
Celularity Inc - Ordinary Shares
26 Apr 19
IPO registration
4:23pm
of the preferred stock of the Corporation (“Preferred Stock”), and to the requirements of applicable law, special meetings of stockholders, for any purpose … is for a stockholders meeting other than an annual meeting, it shall in addition state the purpose or purposes for which the meeting is called
PRE 14A
CELU
Celularity Inc - Ordinary Shares
29 Mar 21
Preliminary proxy
7:34am
or other similar business combination with one or more businesses (a “business combination”), (2) cease its operations except for the purpose … hours for any purpose germane to the Special Meeting.
As previously disclosed on January 8, 2021, the Company entered into a Merger Agreement and Plan
DRS
EX-3.3
eqnf0yr
5 Nov 18
Draft registration statement
12:00am
8-K
EX-10.3
5p62qm qep9hgstufp74
20 May 22
Celularity Inc. Announces $30 Million Private Placement
4:06pm
8-K
EX-10.3
w2x6l 7d5
19 May 23
Entry into a Material Definitive Agreement
4:26pm
8-K
EX-99.1
34a 455y0tm7
31 May 23
THE NEXT EVOLUTION IN CELLULAR MEDICINE Investor Presentation June 2023
5:08pm
8-K
EX-99.1
7qpmbvgokbnv
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
425
EX-99.3
zy75n984
8 Jan 21
Business combination disclosure
7:02am
S-3
EX-4.7
8uqe40l ds8bu19tr4
11 Aug 22
Shelf registration
4:29pm
S-3
EX-4.6
ocixmgy
11 Aug 22
Shelf registration
4:29pm
8-K
EX-99.3
mznqpefu
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
425
EX-99.1
olxp0g uvkyk5d
8 Jan 21
Business combination disclosure
7:02am
DEFA14A
EX-99.1
00j9yvh4
16 Apr 21
Additional proxy soliciting materials
6:17am
8-K
EX-99.1
xfjdcs 46q
16 Apr 21
GX Acquisition Corp. Provides Information Regarding Extension of Deadline to Complete Celularity Business Combination
6:19am
8-K
EX-99.1
n6fb5 i5pb2
17 Jun 22
Other Events
4:57pm
425
kukyj5blg ag00vw
7 Jul 21
Business combination disclosure
4:11pm
S-4/A
EX-10.22
0rf6f7
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am